An 8-year evaluation of antibiotic consumption and antibiotic resistance among Streptococcus pneumoniae from in- and out-patients in Szeged, Hungary

Journal of Chemotherapy

Volumn 19, Issue 5, 2007, Pages 519-527

  Hajdu, E ^a   Matuz, M ^b   Benko, R ^b   Ordas, A ^a   Nagy, Erzsebet ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Amoxicillin; Antibiotic consumption; Ceftriaxone and macrolide resistance; Penicillin; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CHILD; DRUG USE; HUMAN; HUNGARY; INFANT; NONHUMAN; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 36549026376     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.5.519     Document Type: Article

References (30)

1. Eriksen KR. Studies on induced resistance to penicillin in a pneumococcus type I. Acta Pathologica Microbiologica Scandinavica 1945; 22: 398-405.
2. Hansman D, Bullen MM. A resistant pneumococcus. Lancet 1967; ii, 264-265.
3. Hansman D. Type distribution and antibiotic sensitivity of pneumococci from carriers in Kriwina, Trobriand Islands (New Guinea). Med J Australia 1972; ii, 771-773.
4. Kislak JW, Razavi LMB, Daly AK, Finland M. Susceptibility of pneumococci to nine antibiotics. Am J Med Sci 1965; 250: 262-268.
5. Privitera G. Penicillin resistance among Streptococcus pneumoniae in Europe. Diagn Microbiol Infect Dis 1994; 19 (3): 157-161.
6. Linares J, Pallares R, Alonso T et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992; 15 (1): 99-105.
7. Marton A. Pneumococcal antimicrobial resistance the problem in Hungary. Clin Infect Dis 1992; 15 (1): 106-111.
8. Mason EO, Lamberth LB, Kershaw NL et al. Streptococcus pneumoniae in the USA: in uitro susceptibility and pharmacodynamic analysis. J Antimicrob Chemother 2000; 45 (1): 623-631.
9. Bishai W. The in vitro - in vivo paradox in pneumococcal respiratory tract infection. J Antimicrob Chemother 2002; 49 (3): 433-436.
10. Gilbert DN, Moellinger RC, Eliopoulos GM, Sande MA. The Sanford guide to antimicrobial therapy 36th ed. 2006: 7, 9-29.
11. Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases, 6th ed. Churchill Livingstone, Philadelphia, PA, 2005: 2404-2405.
12. Isenberg HD. Clinical Microbiology Procedures Handbook American Society for Microbiology 1st ed. Washington, DC: 1992: 1.20.19.A, 1.20.25.
13. Performance standards for antimicrobial susceptibility testing National Committee for Clinical Laboratory Standards/Clinical and Laboratory Standards Institute M100 1998: Vol. 18 No. 1/ 2001: Vol. 21 No. 1 Table 2G
14. ATC/DDD index 2005. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology, 2005. Available at: http://www.whocc.no/atcddd/ indexdatabase/
15. Official homepage of the Hungarian Central Statistical Office Available at: http://portal.ksh.hu/portal/page?_pageid=37,112477&_dad= portal&_schema=PORTAL
16. EPINFO (Hungarian National Center for Epidemiology - Epidemiological Information) 1999: 6-9.
17. Annual Reports of the National Public Health Institute (1975 - 2003)
18. Marton A, Gulyas M, Munoz R, Tomasz A. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis 1991; 163 (3): 542-548.
19. Marton A, Mészner Zs. Epidemiological studies on drug resistance in Streptococcus pneumoniae in Hungary: an update for the 1990s. Microb Drug Resist 1999; 5 (3): 201-205.
20. Marton A. Epidemiology of resistant pneumococci in Hungary. Microb Drug Resist 1995; 1 (2): 127-130
21. Dobay O, Rozgonyi F, Hajdú E, Nagy E, Knausz M, Amyes SGB. Antibiotic susceptibility and serotypes of Streptococcus pneumoniae isolates from Hungary. J Antimicrob Chemother 2003; 51 (4): 887-893.
22. Felmingham D, Grüneberg RN. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 2000; 45 (2): 191-203.
23. Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 2002; 50: S1, 25-37.
24. Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother 1998; 42 (3): 589-595.
25. Nagai K, Appelbaum PC, Davies TA, et al. Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 Central Eastern European countries. Antimicrob Agents Chemother 2002; 46 (2): 371-377.
26. Richard MP, Aguado AG, Mattina R, Marre R, and SPAR Study Group. Sensitivity to sparfloxacin and other antibiotics, of Streptococcus penumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicenter study. J Antimicrob Chemother 1998; 41 (2): 207-214.
27. Glatz K, Szabó D, Szabó Gy, Boriszova D, Rozgonyi F. Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Antimicrob Chemother 2001; 48 (5): 731-734.
28. Oteo J, Lázaro E, de Abajo FJ, Baquero F, Campos J and Spanish Members of the European Antimicrobial Resistance Surveillance System. Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children's isolates. J Clin Microbiol 2004; 42 (12): 5571-5577.
29. Demachy MC, Vernet-Garnier V, Cottin J. Antimicrobial resistance data on 16,756 Streptococcus pneumoniae isolates in 1999: a Pan-Regional Multicenter Surveillance Study in France. Microb Drug Resist 2005; 11 (4): 323-329.
30. www.EARSS.rivl.nl